• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性大麻素与热应激预处理对离体大鼠心脏梗死面积减小的作用有关。

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts.

作者信息

Joyeux Marie, Arnaud Claire, Godin-Ribuot Diane, Demenge Pierre, Lamontagne Daniel, Ribuot Christophe

机构信息

Laboratoire Stress Cardiovasculaires et Pathologies Associées, Faculté de Pharmacie, Domaine de la Merci, 38706 La Tronche, France.

出版信息

Cardiovasc Res. 2002 Aug 15;55(3):619-25. doi: 10.1016/s0008-6363(02)00268-7.

DOI:10.1016/s0008-6363(02)00268-7
PMID:12160959
Abstract

OBJECTIVE

We have investigated the involvement of the endocannabinoid system in the delayed cardioprotection conferred by heat stress preconditioning in the isolated rat heart.

METHODS

Rats were divided into eight groups (n=7 in each group), subjected to either heat stress (42 degrees C for 15 min, HS groups) or sham anaesthesia (Sham groups). Twenty-four hours later, their hearts were isolated, retrogradely perfused, and subjected to a 30-min occlusion of the left coronary artery followed by 120 min of reperfusion. Some hearts were perfused with either SR 141716 (a cannabinoid CB(1) receptor antagonist, 1 microM), SR 144528 (a CB(2) receptor antagonist, 1 microM) or L-NAME (a NOS inhibitor, 3 microM) 5 min before ischaemia and during the ischaemic period.

RESULTS

The infarct size-reducing effect conferred by heat stress (35.7+/-1.8% in Sham to 14.1+/-0.6% in HS groups) was not altered by the perfusion of SR 141716 (11.2+/-1.5%) but was abolished by both SR 144528 (36.6+/-1.6%) and L-NAME (32.0+/-4.4%). In hearts from non-heat-stressed rats, perfusion with SR 141716 (32.8+/-1.6%), SR 144528 (33.4+/-2.2%) and L-NAME (31.6+/-2.9%) had no effect on infarct size.

CONCLUSION

These results suggest an involvement of endocannabinoids, acting through CB(2) receptors, and NO in the cardioprotection conferred by heat stress against myocardial ischaemia. The possible interaction between both mediators of the heat stress response remains to be determined.

摘要

目的

我们研究了内源性大麻素系统在热应激预处理对离体大鼠心脏延迟性心脏保护作用中的参与情况。

方法

将大鼠分为八组(每组n = 7),分别进行热应激(42℃,15分钟,热应激组)或假麻醉(假手术组)。24小时后,分离心脏,逆行灌注,然后左冠状动脉闭塞30分钟,再灌注120分钟。在缺血前5分钟和缺血期间,一些心脏用SR 141716(一种大麻素CB(1)受体拮抗剂,1μM)、SR 144528(一种CB(2)受体拮抗剂,1μM)或L-NAME(一种一氧化氮合酶抑制剂,3μM)灌注。

结果

热应激带来的梗死面积减小效应(假手术组为35.7±1.8%,热应激组为14.1±0.6%)不受SR 141716灌注(11.2±1.5%)的影响,但被SR 144528(36.6±1.6%)和L-NAME(32.0±4.4%)消除。在非热应激大鼠的心脏中,用SR 141716(32.8±1.6%)、SR 144528(33.4±2.2%)和L-NAME(31.6±2.9%)灌注对梗死面积无影响。

结论

这些结果表明,内源性大麻素通过CB(2)受体发挥作用,以及一氧化氮参与了热应激对心肌缺血的心脏保护作用。热应激反应的这两种介质之间可能的相互作用仍有待确定。

相似文献

1
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts.内源性大麻素与热应激预处理对离体大鼠心脏梗死面积减小的作用有关。
Cardiovasc Res. 2002 Aug 15;55(3):619-25. doi: 10.1016/s0008-6363(02)00268-7.
2
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.作用于CB1大麻素受体的2-花生四烯酸甘油介导一氧化氮在大鼠离体心脏中诱导的延迟性心脏保护作用。
J Cardiovasc Pharmacol. 2006 May;47(5):650-5. doi: 10.1097/01.fjc.0000211752.08949.eb.
3
Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide.大麻素在脂多糖诱导的心脏保护中的作用。
Br J Pharmacol. 2001 Feb;132(4):793-6. doi: 10.1038/sj.bjp.0703902.
4
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart.内源性大麻素在离体大鼠心脏缺血预处理所提供的内皮保护中的作用。
Life Sci. 2003 Mar 7;72(16):1859-70. doi: 10.1016/s0024-3205(02)02474-8.
5
Role of nitric oxide synthases in the infarct size-reducing effect conferred by heat stress in isolated rat hearts.一氧化氮合酶在热应激对离体大鼠心脏梗死面积减小作用中的作用。
Br J Pharmacol. 2001 Apr;132(8):1845-51. doi: 10.1038/sj.bjp.0703942.
6
iNOS is a mediator of the heat stress-induced preconditioning against myocardial infarction in vivo in the rat.诱导型一氧化氮合酶是热应激诱导的大鼠体内心肌梗死预处理的介质。
Cardiovasc Res. 2003 Apr 1;58(1):118-25. doi: 10.1016/s0008-6363(02)00812-x.
7
L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts.缺血预处理后给予L-精氨酸可增强离体大鼠心脏的心脏保护作用。
Eur J Cardiothorac Surg. 2001 Jun;19(6):873-9. doi: 10.1016/s1010-7940(01)00699-6.
8
Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.内源性大麻素通过大鼠心脏中的大麻素CB2受体促进远程缺血预处理。
Eur J Pharmacol. 2008 Jan 28;579(1-3):246-52. doi: 10.1016/j.ejphar.2007.09.034. Epub 2007 Oct 5.
9
Endocannabinoids protect the rat isolated heart against ischaemia.内源性大麻素保护大鼠离体心脏免受缺血损伤。
Br J Pharmacol. 2003 Jun;139(4):805-15. doi: 10.1038/sj.bjp.0705313.
10
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism.花生四烯乙醇胺通过一种新型大麻素机制减少了遭受缺血再灌注的大鼠离体心脏的梗死面积。
Br J Pharmacol. 2005 Nov;146(6):809-16. doi: 10.1038/sj.bjp.0706391.

引用本文的文献

1
Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria.根据改善心脏保护疗法的临床前评估(IMPACT)标准,重新评估大麻素对缺血再灌注损伤的心脏保护作用。
Front Pharmacol. 2024 May 30;15:1382995. doi: 10.3389/fphar.2024.1382995. eCollection 2024.
2
CB2 Cannabinoid Receptor as a Potential Target in Myocardial Infarction: Exploration of Molecular Pathogenesis and Therapeutic Strategies.CB2 大麻素受体作为心肌梗死的潜在靶点:分子发病机制与治疗策略的探索。
Int J Mol Sci. 2024 Jan 30;25(3):1683. doi: 10.3390/ijms25031683.
3
Effects of Environmental Heat Load on Endocannabinoid System Components in Adipose Tissue of High Yielding Dairy Cows.
环境热负荷对高产奶牛脂肪组织中内源性大麻素系统成分的影响。
Animals (Basel). 2022 Mar 21;12(6):795. doi: 10.3390/ani12060795.
4
The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases.内源性大麻素系统与大麻二酚:心血管疾病的过去、现在与展望
Pharmaceuticals (Basel). 2021 Sep 17;14(9):936. doi: 10.3390/ph14090936.
5
Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure.大麻素在心肌病和心力衰竭中的治疗应用。
Oxid Med Cell Longev. 2020 Oct 27;2020:4587024. doi: 10.1155/2020/4587024. eCollection 2020.
6
The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.内源性大麻素系统与心脏病:2型大麻素受体的作用
Cardiovasc Hematol Disord Drug Targets. 2018;18(1):34-51. doi: 10.2174/1871529X18666180206161457.
7
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases.热休克蛋白与兴奋效应在神经退行性疾病诊断和治疗中的应用
Immun Ageing. 2015 Nov 4;12:20. doi: 10.1186/s12979-015-0046-8. eCollection 2015.
8
Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome.大麻素受体 1 抑制可改善心肌梗死后和实验性代谢综合征中的心脏功能和重塑。
J Mol Med (Berl). 2013 Jul;91(7):811-23. doi: 10.1007/s00109-013-1034-0. Epub 2013 May 1.
9
Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.靶向大麻素受体 CB(2)治疗心血管疾病:前景与争议。
Br J Pharmacol. 2012 Sep;167(2):313-23. doi: 10.1111/j.1476-5381.2012.02042.x.
10
Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.心血管疾病中的内源性大麻素系统——新的药物治疗机遇
J Pharm Bioallied Sci. 2011 Jul;3(3):350-60. doi: 10.4103/0975-7406.84435.